131 related articles for article (PubMed ID: 3863819)
1. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9 alpha,11 beta-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels.
Pugliese G; Spokas EG; Marcinkiewicz E; Wong PY
J Biol Chem; 1985 Nov; 260(27):14621-5. PubMed ID: 3863819
[TBL] [Abstract][Full Text] [Related]
2. 9 alpha, 11 beta-prostaglandin F2: a new prostanoid with selective biosynthesis and unique biological activity.
Pugliese G; Marcinkiewicz E; Wong PY
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():50-4. PubMed ID: 2959104
[No Abstract] [Full Text] [Related]
3. Metabolism of prostaglandin D2 in isolated rat lung: the stereospecific formation of 9 alpha,11 beta-prostaglandin F2 from prostaglandin D2.
Hayashi H; Ito S; Watanabe K; Negishi M; Shintani T; Hayaishi O
Biochim Biophys Acta; 1987 Feb; 917(3):356-64. PubMed ID: 3467796
[TBL] [Abstract][Full Text] [Related]
4. Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans.
Liston TE; Roberts LJ
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6030-4. PubMed ID: 3862115
[TBL] [Abstract][Full Text] [Related]
5. Potential role for prostaglandin F2 alpha, D2, E2 and thromboxane A2 in mediating the metabolic and hemodynamic actions of sympathetic nerves in perfused rat liver.
Iwai M; Gardemann A; Püschel G; Jungermann K
Eur J Biochem; 1988 Jul; 175(1):45-50. PubMed ID: 3165341
[TBL] [Abstract][Full Text] [Related]
6. PGD2 is transformed by human coronary arteries to 9 alpha, 11 beta-PGF2, which contracts human coronary artery rings.
Roberts LJ; Seibert K; Liston TE; Tantengco MV; Robertson RM
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():427-9. PubMed ID: 2959090
[No Abstract] [Full Text] [Related]
7. Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase.
Watanabe K; Iguchi Y; Iguchi S; Arai Y; Hayaishi O; Roberts LJ
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1583-7. PubMed ID: 3456602
[TBL] [Abstract][Full Text] [Related]
8. Isomeric prostaglandin F2 compounds arising from prostaglandin D2: a family of icosanoids produced in vivo in humans.
Wendelborn DF; Seibert K; Roberts LJ
Proc Natl Acad Sci U S A; 1988 Jan; 85(2):304-8. PubMed ID: 3422430
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor.
Altin JG; Bygrave FL
Biochem J; 1988 Feb; 249(3):677-85. PubMed ID: 3128268
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of prostaglandins D2 and F2 alpha in primary cultures of rat hepatocytes.
Sago T; Nakayama R; Okumura T; Saito K
Biochim Biophys Acta; 1986 Dec; 879(3):330-8. PubMed ID: 3465372
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin D2 is metabolized in humans to 9 alpha,11 beta-prostaglandin F2, a novel biologically active prostaglandin.
Liston TE; Oates JA; Roberts LJ
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():365-7. PubMed ID: 2936123
[No Abstract] [Full Text] [Related]
13. Studies on the characterisation of prostanoid receptors: a proposed classification.
Kennedy I; Coleman RA; Humphrey PP; Levy GP; Lumley P
Prostaglandins; 1982 Nov; 24(5):667-89. PubMed ID: 6131499
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane synthase inhibition causes re-direction of prostaglandin endoperoxides to prostaglandin D2 during collagen stimulated aggregation of human platelet rich plasma.
Orchard MA; Waddell KA; Lewis PJ; Blair IA
Thromb Res; 1985 Sep; 39(6):701-10. PubMed ID: 3936223
[TBL] [Abstract][Full Text] [Related]
15. The effect of prostaglandin D2 on the blood vessels of the perfused isolated cotyledon of the human placenta.
Abramovich DR; Page KR; Parkin AM
Br J Pharmacol; 1984 Jan; 81(1):19-21. PubMed ID: 6584189
[TBL] [Abstract][Full Text] [Related]
16. Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer.
Liston TE; Roberts LJ
J Biol Chem; 1985 Oct; 260(24):13172-80. PubMed ID: 3863815
[TBL] [Abstract][Full Text] [Related]
17. Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man.
Hardy CC; Holgate ST; Robinson C
Br J Pharmacol; 1986 Mar; 87(3):563-8. PubMed ID: 3467804
[TBL] [Abstract][Full Text] [Related]
18. Presence of prostaglandin D2, E2 and F2 alpha in rat pancreatic islets.
Horie H; Narumiya S; Matsuyama T; Nonaka K; Tarui S
Prostaglandins Leukot Med; 1984 Oct; 16(1):39-44. PubMed ID: 6393143
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2.
Giles H; Bolofo ML; Lydford SJ; Martin GR
Br J Pharmacol; 1991 Oct; 104(2):541-9. PubMed ID: 1665742
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation.
Hung SC; Ghali NI; Venton DL; Le Breton GC
Prostaglandins; 1982 Aug; 24(2):195-206. PubMed ID: 6293001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
